Advertisement
Screener

Xencor, Inc (XNCR) Form D

Xencor, Inc Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2021-11-19: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-11-12; Total offering amount $25,000,000.
  • 2013-07-01: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2013-06-26; Total offering amount $9,999,998.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2021-11-19Rule 506(b)Equity2021-11-12$25,000,000$25,000,000$01
2013-07-01Rule 506Equity2013-06-26$9,999,998$7,597,653$2,402,34510

Similar stocks

Stock NameCountryMarket CapPE Ratio
Septerna, Inc. (SEPN)United States$1.783B-63.01
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82